These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21675272)

  • 21. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
    Cardio-Sis Study Group
    J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Valley/peak ratio and pressure changes during treatment with fosinopril in hypertensive elderly patients].
    Cicconetti P; Salza MC; Rizzo V; Bianchi A; Capponi L; Marigliano V
    Clin Ter; 1996; 147(7-8):359-64. PubMed ID: 9118617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Individual chronotherapy of essential hypertension and compliance of patients with treatment scheme].
    Khromtsova OM
    Ter Arkh; 2008; 80(9):29-33. PubMed ID: 19555033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises.
    Hirschl MM; Binder M; Bur A; Herkner H; Brunner M; Müllner M; Sterz F; Laggner AN
    Arch Intern Med; 1995 Nov; 155(20):2217-23. PubMed ID: 7487244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reduction of hypertensive changes in the electrocardiogram during antihypertensive treatment].
    Patzschke U; Manegold C; Wolff G
    MMW Munch Med Wochenschr; 1979 Jun; 121(23):795-7. PubMed ID: 111073
    [No Abstract]   [Full Text] [Related]  

  • 29. The development of coronary insufficiency during prolonged treatment of essential hypertension.
    Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV
    Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronobiologic assessment of antihypertensive therapy.
    Tamura K; Kohno I; Tsuruta I; Ijiri H; Nakamura T
    Ann Ist Super Sanita; 1993; 29(4):693-704. PubMed ID: 7985930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
    Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
    Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to antihypertensive therapy affects Ambulatory Arterial Stiffness Index.
    Berni A; Ciani E; Cecioni I; Poggesi L; Abbate R; Boddi M
    Eur J Intern Med; 2011 Feb; 22(1):93-8. PubMed ID: 21238902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E
    Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Readjustment of antihypertensive treatment in patients with unsatisfactory blood pressure control.
    Säkö S
    Clin Ther; 1984; 6(4):404-10. PubMed ID: 6467277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C; Michey I; Meani S; Severgnini B; Fusi V; Salerno M; Valerio C; Magrini F; Zanchetti A
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accomplish more blood pressure lowering with initial fixed-dose combination therapy.
    Cardiovasc J Afr; 2009; 20(2):153. PubMed ID: 19421660
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in parameters of orthogonal ECG in hypertensive patients given combined antihypertensive treatment].
    Sakhnova TA; Blinova EV; Chikhladze NM; Samedova KhF; Kolos IP; Chazova IE
    Ter Arkh; 2008; 80(1):38-40. PubMed ID: 18326225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection rates of inter-arm systolic blood pressure difference vary with blood pressure levels in hypertensive patients under antihypertensive therapy.
    Sun H; Li P; Su H; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Apr; 172(3):e419-20. PubMed ID: 24444483
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intensive control of arterial pressure prevents renal impairement in patients with diabetes mellitus].
    Makolkin VI
    Kardiologiia; 2009; 49(2):91-5. PubMed ID: 19254227
    [No Abstract]   [Full Text] [Related]  

  • 40. Brachial-brachial index of systolic blood pressure in the patients under anti-hypertensive therapy.
    Sun H; Li P; Su H; Wang W; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Jul; 174(3):802-4. PubMed ID: 24814541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.